Table 3.
OR | 95% CI | P Value | |
---|---|---|---|
Univariate logistic regression | |||
Duration of diabetes (yrs) | 1.05 | 1.00–1.09 | 0.042∗ |
Type 1 diabetes | 2.09 | 0.89–4.89 | 0.090 |
Baseline grade of DR | 1.48 | 1.23–1.76 | 0.001∗ |
Scatter laser treatment† | 3.75 | 1.90–7.40 | 0.001∗ |
Mean HbA1c (NGSP %) | 1.28 | 1.13–1.44 | 0.001∗ |
Mean sBP (mmHg) | 1.00 | 0.99–1.02 | 0.68 |
log[Mean urine ACR] (mg/mmol) | 1.28 | 1.07–1.52 | 0.005∗ |
Mean hemoglobin (g/dl) | 0.92 | 0.76–1.12 | 0.43 |
HIV positive | 0.20 | 0.05–0.85 | 0.029∗ |
Baseline LDL cholesterol (mmol/l) | 0.99 | 0.72–1.34 | 0.92 |
Baseline HDL cholesterol (mmol/l) | 2.24 | 0.98–5.14 | 0.057 |
Baseline triglycerides (mmol/l) | 0.78 | 0.57–1.06 | 0.11 |
Sex (male) | 1.04 | 0.58–1.87 | 0.89 |
Age (yrs) | 0.99 | 0.97–1.01 | 0.49 |
Multivariate logistic regression | |||
Mean HbA1c (NGSP %) | 1.27 | 1.12–1.45 | 0.001∗ |
Baseline grade of DR | 1.39 | 1.02–1.91 | 0.040∗ |
HIV positive | 0.16 | 0.03–0.78 | 0.023∗ |
Type 1 diabetes | 2.27 | 0.87–5.89 | 0.094 |
Scatter laser treatment† | 1.45 | 0.43–4.88 | 0.54 |
ACR = albumin-to-creatinine ratio; CI = confidence interval; DR = diabetic retinopathy; HbA1c = glycosylated hemoglobin; HDL = high-density lipoprotein; HIV = human immunodeficiency virus; LDL = low-density lipoprotein; NGSP = National Glycohemoglobin Standardisation Program; OR = odds ratio; sBP = systolic blood pressure.
Indicates statistical significance.
Scatter laser treatment received any time between baseline and 24 months.